RenovaCare_FullLogo_RGB-full.png
RenovaCare Announces Termination of StemCell Systems R&D Agreement
May 03, 2022 10:06 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for...
RenovaCare_FullLogo_RGB-full.png
RenovaCare Announces Management Changes
March 24, 2022 08:30 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for...
RenovaCare, Inc.
RenovaCare Provides Clinical and Corporate Update
March 09, 2022 15:35 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for...
RenovaCare Intellectual Property Update
RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent
October 14, 2021 08:30 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...
RenovaCare Clinical Trial Update
RenovaCare Provides Update on Clinical Trial for the SkinGun™ and CellMist™ System for Wound Healing
July 22, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for the regeneration of skin and other organs and...
RenovaCare Clinical Trial to Start at U.S. Burn Centers
RenovaCare Clinical Trial to Start at U.S. Burn Centers
June 07, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...
RenovaCare Responds to SEC Complaint
RenovaCare Responds to SEC Complaint
June 01, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced that it intends to vigorously defend itself and its stockholders against...
RenovaCare, Inc.
FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial
May 06, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that its Investigational Device Exemption (IDE) application has been granted...
Dr. Kaiyo Nedd
RenovaCare Announces Organizational Changes and Appointment of New Officers
March 30, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare CellMist™ and SkinGun™ System
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
February 25, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...